Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Ginekologia i Perinatologia Praktyczna
MENU
Na skróty Zdeponuj artykuł Wytyczne dla autorów Ahead of print Recenzenci 2023

dostęp otwarty

Tom 2, Nr 4 (2017)
Wytyczne / stanowisko ekspertów
Opublikowany online: 2017-10-31
Pokaż PDF Pobierz plik PDF
Pobierz cytowanie

Zaburzenia rozwoju płodu spowodowane spożywaniem alkoholu przez kobietę w ciąży. Karmienie piersią a alkohol

Zespół ekspertów
Ginekologia i Perinatologia Praktyczna 2017;2(4):176-190.

dostęp otwarty

Tom 2, Nr 4 (2017)
Rekomendacje
Opublikowany online: 2017-10-31

Streszczenie

Brak

Streszczenie

Brak

Pełny tekst:

Pokaż PDF Pobierz plik PDF
Pobierz cytowanie
Informacje o artykule
Tytuł

Zaburzenia rozwoju płodu spowodowane spożywaniem alkoholu przez kobietę w ciąży. Karmienie piersią a alkohol

Czasopismo

Ginekologia i Perinatologia Praktyczna

Numer

Tom 2, Nr 4 (2017)

Typ artykułu

Wytyczne / stanowisko ekspertów

Strony

176-190

Opublikowany online

2017-10-31

Wyświetlenia strony

1566

Wyświetlenia/pobrania artykułu

24680

Rekord bibliograficzny

Ginekologia i Perinatologia Praktyczna 2017;2(4):176-190.

Autorzy

Zespół ekspertów

Referencje (96)
  1. Burd L, Blair J, Dropps K. Prenatal alcohol exposure, blood alcohol concentrations and alcohol elimination rates for the mother, fetus and newborn. J Perinatol. 2012; 32(9): 652–659.
    CrossRefPubMed
  2. Lemoine P, Harousseau H, Borteyru JP, et al. Les enfants de parents alcoolique. Ouest Med. 1968; 21: 476–82.
  3. May PA, Gossage JP, White-Country M, et al. Alcohol consumption and other maternal risk factors for fetal alcohol syndrome among three distinct samples of women before, during, and after pregnancy: the risk is relative. Am J Med Genet C Semin Med Genet. 2004; 127C(1): 10–20.
    CrossRefPubMed
  4. O'Leary CM, Nassar N, Kurinczuk JJ, et al. Prenatal alcohol exposure and risk of birth defects. Pediatrics. 2010; 126(4): e843–e850.
    CrossRefPubMed
  5. Jakubczyk A. Uzależnienie, picie szkodliwe i ryzykowne – podstawowe definicje w świetle najważniejszych systemów klasyfikacyjnych. [W:] M. Wojnar (red.) Medyczne aspekty uzależnienia od alkoholu, PARPA Warszawa, 2017.
  6. Abel EL, Sokol RJ. Fetal alcohol syndrome is now leading cause of mental retardation. Lancet. 1986; 2(8517): 1222.
    PubMed
  7. Jones KL, Smith DW, Ulleland CN, et al. Pattern of malformation in offspring of chronic alcoholic mothers. Lancet. 1973; 1(7815): 1267–1271.
    PubMed
  8. Stratton K, Howe C, Battaglia F. Fetal Alcohol Syndrome: Diagnosis, Epidemilogy, Prevention, and Treatment. Institute of Medicine, Washington 1996.
  9. Hagda JF, Balachova T, Bertrand J, et al. Neurobehavioral disorder associated with prenatal alcohol exposure. Pediatrics. 2014; 27: 95–7.
  10. Popova S, Lange S, Probst C, et al. Estimation of national, regional, and global prevalence of alcohol use during pregnancy and fetal alcohol syndrome: a systematic review and meta-analysis. Lancet. 2017; 5(3): e290–e299.
  11. Carpenter B. Pedagogically bereft! Improving learning outcomes for children with foetal alcohol spectrum disorders. BJSE. 2011; 38(1): 37–43.
    CrossRef
  12. Petković G, Barišić I. Prevalence of fetal alcohol syndrome and maternal characteristics in a sample of schoolchildren from a rural province of Croatia. Int J Environ Res Public Health. 2013; 10(4): 1547–1561.
    CrossRefPubMed
  13. May PA, Gossage JP. Maternal risk factors for fetal alcohol spectrum disorders: not as simple as it might seem. Alcohol Res Health. 2011; 34(1): 15–26.
    PubMed
  14. Okulicz-Kozaryn K, Borkowska M, Brzózka K. FASD Prevalence among Schoolchildren in Poland. J Appl Res Intellect Disabil. 2017; 30(1): 61–70.
    CrossRefPubMed
  15. Chudley AE, Conry J, Cook JL, et al. Public Health Agency of Canada's National Advisory Committee on Fetal Alcohol Spectrum Disorder. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005; 172(5 Suppl): S1–S21.
    CrossRefPubMed
  16. May PA, Gossage JP. Estimating the prevalence of fetal alcohol syndrome. A summary. Alcohol Res Health. 2001; 25(3): 159–167.
    PubMed
  17. Astley SJ. Profile of the first 1,400 patients receiving diagnostic evaluations for fetal alcohol spectrum disorder at the Washington State Fetal Alcohol Syndrome Diagnostic & Prevention Network. Can J Clin Pharmacol. 2010; 17(1): e132–e164.
    PubMed
  18. May PA, Keaster C, Bozeman R, et al. Prevalence and characteristics of fetal alcohol syndrome and partial fetal alcohol syndrome in a Rocky Mountain Region City. Drug Alcohol Depend. 2015; 155: 118–127.
    CrossRefPubMed
  19. Roozen S, Peters GJY, Kok G, et al. Worldwide Prevalence of Fetal Alcohol Spectrum Disorders: A Systematic Literature Review Including Meta-Analysis. Alcohol Clin Exp Res. 2016; 40(1): 18–32.
    CrossRefPubMed
  20. Centers for Disease Control and Prevention (CDC). Alcohol use among pregnant and nonpregnant women of childbearing age - United States, 1991-2005. MMWR Morb Mortal Wkly Rep. 2009; 58(19): 529–532.
    PubMed
  21. Astley SJ, Stachowiak J, Clarren SK, et al. Application of the fetal alcohol syndrome facial photographic screening tool in a foster care population. J Pediatr. 2002; 141(5): 712–717.
    CrossRefPubMed
  22. Hoyme HE, May PA, Kalberg WO, et al. A practical clinical approach to diagnosis of fetal alcohol spectrum disorders: clarification of the 1996 institute of medicine criteria. Pediatrics. 2005; 115(1): 39–47.
    CrossRefPubMed
  23. Hoyme HE, Kalberg WO, Elliott AJ, et al. Updated Clinical Guidelines for Diagnosing Fetal Alcohol Spectrum Disorders. Pediatrics. 2016; 138(2).
    CrossRefPubMed
  24. Chudley AE, Conry J, Cook JL, et al. Public Health Agency of Canada's National Advisory Committee on Fetal Alcohol Spectrum Disorder. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005; 172(5 Suppl): S1–S21.
    CrossRefPubMed
  25. Cook JL, Green CR, Lilley CM, et al. Canada Fetal Alcohol Spectrum Disorder Research Network. Fetal alcohol spectrum disorder: a guideline for diagnosis across the lifespan. CMAJ. 2016; 188(3): 191–197.
    CrossRefPubMed
  26. Astley SJ, Clarren SK. Diagnosing the full spectrum of fetal alcohol-exposed individuals: introducing the 4-digit diagnostic code. Alcohol Alcohol. 2000; 35(4): 400–410.
    CrossRefPubMed
  27. Riley EP, Infante MA, Warren KR. Fetal alcohol spectrum disorders: an overview. Neuropsychol Rev. 2011; 21(2): 73–80.
    CrossRefPubMed
  28. Lebel C, Roussotte F, Sowell ER. Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain. Neuropsychol Rev. 2011; 21(2): 102–118.
    CrossRefPubMed
  29. Wozniak JR, Muetzel RL. What does diffusion tensor imaging reveal about the brain and cognition in fetal alcohol spectrum disorders? Neuropsychol Rev. 2011; 21(2): 133–147.
    CrossRefPubMed
  30. Astley S, Aylward E, Olson H, et al. Magnetic Resonance Imaging Outcomes From a Comprehensive Magnetic Resonance Study of Children With Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2009; 33(10): 1671–1689.
    CrossRef
  31. Heller M, Burd L. Review of ethanol dispersion, distribution, and elimination from the fetal compartment. Birth Defects Res A Clin Mol Teratol. 2014; 100(4): 277–283.
    CrossRefPubMed
  32. Jones KL, Jones MC, del Campo M. Smith”s Recognizable patterns of human malformation. Elsevier Saunders 2013.
  33. Feldman HS, Jones KL, Lindsay S, et al. Prenatal alcohol exposure patterns and alcohol-related birth defects and growth deficiencies: a prospective study. Alcohol Clin Exp Res. 2012; 36(4): 670–676.
    CrossRefPubMed
  34. Abel EL, Hannigan JH. Maternal risk factors in fetal alcohol syndrome: provocative and permissive influences. Neurotoxicol Teratol. 1995; 17(4): 445–462.
    PubMed
  35. Warren KR, Li TK. Genetic polymorphisms: impact on the risk of fetal alcohol spectrum disorders. Birth Defects Res A Clin Mol Teratol. 2005; 73(4): 195–203.
    CrossRefPubMed
  36. Wass TS, Persutte WH, Hobbins JC. The impact of prenatal alcohol exposure on frontal cortex development in utero. Am J Obstet Gynecol. 2001; 185(3): 737–742.
    CrossRefPubMed
  37. Handmaker NS, Rayburn WF, Meng C, et al. Impact of alcohol exposure after pregnancy recognition on ultrasonographic fetal growth measures. Alcohol Clin Exp Res. 2006; 30(5): 892–898.
    CrossRefPubMed
  38. Kfir M, Yevtushok L, Onishchenko S, et al. Can prenatal ultrasound detect the effects of in-utero alcohol exposure? A pilot study. Ultrasound Obstet Gynecol. 2009; 33(6): 683–689.
    CrossRefPubMed
  39. Montag AC, Hull AD, Yevtushok L, et al. CIFASD. Second-Trimester Ultrasound as a Tool for Early Detection of Fetal Alcohol Spectrum Disorders. Alcohol Clin Exp Res. 2016; 40(11): 2418–2425.
    CrossRefPubMed
  40. Handmaker NS, Wilburn P. Motivational Interventions in Prenatal Clinics Alcohol Research & Health Vol. Alcohol Res Health. 2001(3): 219–229.
  41. Floyd RL, Weber MK, Denny C, et al. Prevention of fetal alcohol spectrum disorders. Dev Disabil Res Rev. 2009; 15(3): 193–199.
    CrossRefPubMed
  42. Wright TE, Terplan M, Ondersma SJ, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016; 215(5): 539–547.
    CrossRefPubMed
  43. Anderson P, Gual A, Colom J. Alkohol i podstawowa opieka zdrowotna. Kliniczne wytyczne rozpoznawania i krótkiej interwencji (Alcohol and Primary Health Care: Clinical Guidelines on Identification and Brief Interventions. Department of Health of the Government of Catalonia, Barcelona. PARPAMEDIA, Warszawa 2005.
  44. McNamara TK, Orav EJ, Wilkins-Haug L, et al. Risk during pregnancy--self-report versus medical record. Am J Obstet Gynecol. 2005; 193(6): 1981–1985.
    CrossRefPubMed
  45. Hughes SC, Chambers CD, Kassem N, et al. Inconsistent report of pre-pregnancy-recognition alcohol use by Latinas. Matern Child Health J. 2009; 13(6): 857–864.
    CrossRefPubMed
  46. Sobell LC, Agrawal S, Sobell MB, et al. Comparison of a quick drinking screen with the timeline followback for individuals with alcohol problems. J Stud Alcohol. 2003; 64(6): 858–861.
    CrossRefPubMed
  47. Dum M, Sobell LC, Sobell MB, et al. A Quick Drinking Screen for identifying women at risk for an alcohol-exposed pregnancy. Addict Behav. 2009; 34(9): 714–716.
    CrossRefPubMed
  48. Balachova T, Sobell LC, Agrawal S, et al. Evaluating alcohol use among Russian women at risk for an alcohol-exposed pregnancy: A comparison of three measures of alcohol use. J Ethn Subst Abuse. 2016 [Epub ahead of print]: 1–11.
    CrossRefPubMed
  49. Sobell L, Sobell M. Timeline follow-back: A technique for assessing selfreported alcohol consumption. Measuring Alcohol Consumption. 1992: 41–72.
    CrossRef
  50. Lange S, Shield K, Koren G, et al. A comparison of the prevalence of prenatal alcohol exposure obtained via maternal self-reports versus meconium testing: a systematic literature review and meta-analysis. BMC Pregnancy Childbirth. 2014; 14: 127.
    CrossRefPubMed
  51. McQuire C, Paranjothy S, Hurt L, et al. Objective Measures of Prenatal Alcohol Exposure: A Systematic Review. Pediatrics. 2016; 138(3).
    CrossRefPubMed
  52. Nelson L. Goldfrank’s Toxicologic Emergencies. McGraw-Hill Medical, New York 2011.
  53. Carson G. Alcohol use and pregnancy consensus clinical guidelines. Society of Obstetricians and Gynaecologists of Canada. www.guideline.gov.
  54. Australian guidelines to reduce health risks from drinking alcohol. National Health and Medical Research Council. www.nhmrc.gov.au.
  55. Matheson I, Kristensen K, Lunde PK. Drug utilization in breast-feeding women. A survey in Oslo. Eur J Clin Pharmacol. 1990; 38(5): 453–459.
    CrossRefPubMed
  56. Little RE, Lambert MD, Worthington-Roberts B. Drinking and smoking at 3 months postpartum by lactation history. Paediatr Perinat Epidemiol. 1990; 4(3): 290–302.
    CrossRefPubMed
  57. Parackal S, Ferguson E, Harraway J. Alcohol and tobacco consumption among 6-24-months post-partum New Zealand women. Matern Child Nutr. 2007; 3(1): 40–51.
    CrossRefPubMed
  58. Breslow RA, Falk DE, Fein SB, et al. Alcohol consumption among breastfeeding women. Breastfeed Med. 2007; 2(3): 152–157.
    CrossRefPubMed
  59. Giglia RC, Binns CW. Patterns of alcohol intake of pregnant and lactating women in Perth, Australia. Drug Alcohol Rev. 2007; 26(5): 493–500.
    CrossRefPubMed
  60. Maloney E, Hutchinson D, Burns L, et al. Prevalence and predictors of alcohol use in pregnancy and breastfeeding among Australian women. Birth. 2011; 38(1): 3–9.
    CrossRefPubMed
  61. Alvik A, Haldorsen T, Lindemann R. Alcohol consumption, smoking and breastfeeding in the first six months after delivery. Acta Paediatr. 2006; 95(6): 686–693.
    CrossRefPubMed
  62. Giglia RC, Binns CW. Alcohol, pregnancy and breastfeeding; a comparison of the 1995 and 2001 National Health Survey data. Breastfeed Rev. 2008; 16(1): 17–24.
    PubMed
  63. Pepino MY, Mennella JA. Advice given to women in Argentina about breast-feeding and the use of alcohol. Rev Panam Salud Publica. 2004; 16(6): 408–414.
    CrossRefPubMed
  64. Haastrup MB, Pottegård A, Damkier P. Alcohol and breastfeeding. Basic Clin Pharmacol Toxicol. 2014; 114(2): 168–173.
    CrossRefPubMed
  65. Lawton ME. Alcohol in breast milk. Aust N Z J Obstet Gynaecol. 1985; 25(1): 71–73.
    CrossRefPubMed
  66. Dietary Guidelines for Americans. 2010. United States Department of Agriculture. Center for Nutrition Policy and Promotion. www.cnpp.usda.gov/dietaryguidelines (2010).
  67. Healthy habits before, during and after pregnancy. 1st edn: The Danish Health and Medicines Authority, 2010. www.sst.dk/udgivelser/2010 (2010).
  68. American Academy of Pediatrics. Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2012; 129: 827–841.
  69. American Academy of Pediatrics. Committee on Drugs: The Transfer of Drugs and Therapeutics Into Human Breast Milk: An Update on Selected Topics. Pediatrics. 2013; 132: e796–e809.
  70. RARHA (2016) Comparative monitoring of alcohol epidemiology across the EU. Baseline assessment and suggestions for future action. Synthesis report. RARHA Work Package 4. http://www.parpa.pl/images/file/Comparative%20monitoring%20of%20alcohol%20epidemiology%20across%20the%20EU.pdf (2016).
  71. Tough S, Tofflemire K, Clarke M, et al. Do women change their drinking behaviors while trying to conceive? An opportunity for preconception counseling. Clin Med Res. 2006; 4(2): 97–105.
    CrossRefPubMed
  72. Wojtyła, A., Kapka-Skrzypczak, L., Diatczyk, J., Fronczak, A., Paprzycki, P. Alcohol-related Developmental Origin of Adult Health – population studies in Poland among mothers and newborns (2010-2012). Ann Agric Environ Med. 2012; 19(3): 365–377.
  73. Wdowiak A, Pucek W, Makara-Studzińska M, et al. Ocena wybranych zachowań zdrowotnych kobiet leczonych technologiami rozrodu wspomaganego z powodu niepłodności. European J Med Technologies. 2014; 3(4): 7–16.
  74. Green PP, McKnight-Eily LR, Tan CH, et al. Vital Signs: Alcohol-Exposed Pregnancies--United States, 2011-2013. MMWR Morb Mortal Wkly Rep. 2016; 65(4): 91–97.
    CrossRefPubMed
  75. Anderson P, Gual A, Colom J. Alkohol i podstawowa opieka zdrowotna. Kliniczne wytyczne rozpoznawania i krótkiej interwencji (Alcohol and Primary Health Care: Clinical Guidelines on Identification and Brief Interventions. Department of Health of the Government of Catalonia, Barcelona. PARPAMEDIA, Warszawa 2005.
  76. Sokol R, Martier S, Ager J. The T-ACE questions: Practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989; 160(4): 863–870.
    CrossRef
  77. Russell M, Martier SS, Sokol RJ, et al. Screening for pregnancy risk-drinking. Alcohol Clin Exp Res. 1994; 18(5): 1156–1161.
    CrossRefPubMed
  78. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction. 1993; 88(6): 791–804.
    CrossRefPubMed
  79. Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res. 2007; 31(7): 1208–1217.
    CrossRefPubMed
  80. Dum M, Sobell LC, Sobell MB, et al. A Quick Drinking Screen for identifying women at risk for an alcohol-exposed pregnancy. Addict Behav. 2009; 34(9): 714–716.
    CrossRefPubMed
  81. Wright TE, Terplan M, Ondersma SJ, et al. The role of screening, brief intervention, and referral to treatment in the perinatal period. Am J Obstet Gynecol. 2016; 215(5): 539–547.
    CrossRefPubMed
  82. Joya X, Marchei E, Salat-Batlle J, et al. Fetal exposure to ethanol: relationship between ethyl glucuronide in maternal hair during pregnancy and ethyl glucuronide in neonatal meconium. Clin Chem Lab Med. 2016; 54(3): 427–435.
    CrossRefPubMed
  83. Miller WR, Rollnick S. Dialog motywujący – Jak pomóc ludziom w zmianie. Wydawnictwo Uniwersytetu Jagiellońskiego, Kraków 2014.
  84. Britt E, Hudson SM, Blampied NM. Motivational interviewing in health settings: a review. Patient Educ Couns. 2004; 53(2): 147–155.
    CrossRefPubMed
  85. Stade BC, Bailey C, Dzendoletas D, et al. Psychological and/or educational interventions for reducing alcohol consumption in pregnant women and women planning pregnancy. Cochrane Database Syst Rev. 2009(2): CD004228.
    CrossRefPubMed
  86. Morton K, Beauchamp M, Prothero A, et al. The effectiveness of motivational interviewing for health behaviour change in primary care settings: a systematic review. Health Psychol Rev. 2015; 9(2): 205–223.
    CrossRefPubMed
  87. Lundahl B, Burke BL. The effectiveness and applicability of motivational interviewing: a practice-friendly review of four meta-analyses. J Clin Psychol. 2009; 65(11): 1232–1245.
    CrossRefPubMed
  88. Handmaker NS, Miller WR, Manicke M. Findings of a pilot study of motivational interviewing with pregnant drinkers. J Stud Alcohol. 1999; 60(2): 285–287.
    CrossRefPubMed
  89. Floyd RL, Sobell M, Velasquez MM, et al. Project CHOICES Efficacy Study Group. Preventing alcohol-exposed pregnancies: a randomized controlled trial. Am J Prev Med. 2007; 32(1): 1–10.
    CrossRefPubMed
  90. Ingersoll KS, Ceperich SD, Hettema JE, et al. Preconceptional motivational interviewing interventions to reduce alcohol-exposed pregnancy risk. J Subst Abuse Treat. 2013; 44(4): 407–416.
    CrossRefPubMed
  91. Ceperich SD, Ingersoll KS. Motivational interviewing + feedback intervention to reduce alcohol-exposed pregnancy risk among college binge drinkers: determinants and patterns of response. J Behav Med. 2011; 34(5): 381–395.
    CrossRefPubMed
  92. Elsinga J, de Jong-Potjer LC, van der Pal-de Bruin KM, et al. The effect of preconception counselling on lifestyle and other behaviour before and during pregnancy. Womens Health Issues. 2008; 18(6 Suppl): S117–S125.
    CrossRefPubMed
  93. Ondersma SJ, Svikis DS, Thacker LR, et al. A randomised trial of a computer-delivered screening and brief intervention for postpartum alcohol use. Drug Alcohol Rev. 2016; 35(6): 710–718.
    CrossRefPubMed
  94. Lui S, Terplan M, Smith EJ. Psychosocial interventions for women enrolled in alcohol treatment during pregnancy. Cochrane Database Syst Rev. 2008(3): CD006753.
    CrossRefPubMed
  95. Hussein N, Kai J, Qureshi N. The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: A systematic review. Eur J Gen Pract. 2016; 22(1): 42–52.
    CrossRefPubMed
  96. Scobie G, Woodman K. Interventions to reduce alcohol consumption during pregnancy. NHS Health Scotland, Edinburgh 2017.

Regulamin

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl